Insufficient Information to Provide Specific Imaging Recommendations
The question lacks critical clinical context needed to make evidence-based imaging recommendations. Without knowing the underlying condition being treated with Bactrim (trimethoprim-sulfamethoxazole), the nature of "worsening," and the patient's clinical presentation, no specific imaging guidance can be provided.
Critical Missing Information
The provided evidence focuses exclusively on:
- Breast cancer screening and diagnosis 1, 2
- Inflammatory breast conditions 3
- Nipple discharge evaluation 4
- Community-acquired pneumonia 5, 6
- Intra-abdominal infections 7
- Recurrent UTIs 8
- TMP-SMX adverse reactions 9, 10, 11, 12, 13
None of this evidence addresses the clinical scenario presented.
What You Need to Determine Next
Immediately clarify:
- Primary diagnosis: UTI? Pneumonia? Skin/soft tissue infection? Other?
- How is she worsening: Fever progression? Hemodynamic instability? Spreading erythema? Respiratory distress? Altered mental status?
- Duration of symptoms before treatment: Was diagnosis confirmed?
- Current vital signs and clinical stability
- Initial imaging already performed: What did the ultrasound show?
General Principles for Treatment Failure at 48 Hours
When a patient worsens on appropriate antibiotics after 2 days:
Consider:
- Resistant organism requiring culture-guided therapy change
- Wrong diagnosis (non-infectious etiology)
- Complications (abscess, empyema, metastatic infection)
- Drug reaction (TMP-SMX can cause DRESS syndrome 10, aseptic meningitis 9, 11, toxic epidermal necrolysis 12)
Imaging decisions depend entirely on the suspected source:
- Pyelonephritis not responding → CT abdomen/pelvis with contrast
- Pneumonia worsening → Repeat chest imaging, consider CT chest
- Cellulitis spreading → Usually clinical diagnosis; imaging if concern for abscess/necrotizing infection
- Intra-abdominal source → CT abdomen/pelvis 7
Provide the specific clinical scenario for targeted imaging recommendations.